Translational pharmacokinetic-pharmacodynamic modeling for an orally available novel inhibitor of anaplastic lymphoma kinase and c-Ros oncogene 1. [electronic resource]
Producer: 20141125Description: 67-76 p. digitalISSN:- 1521-0103
- Administration, Oral
- Aminopyridines
- Anaplastic Lymphoma Kinase
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Female
- Humans
- Lactams
- Lactams, Macrocyclic -- pharmacokinetics
- Mice
- Models, Biological
- NIH 3T3 Cells
- Protein Kinase Inhibitors -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Pyrazoles
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.